SIM
CKPT

Sonora Investment Management’s Checkpoint Therapeutics CKPT Stock Holding History

Sonora Investment Management’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$0 Hold
12
– – ﹤0.01% 1076
2021
Q2 		$0 Buy
+12
New +$333 ﹤0.01% 1001

Other funds holding CKPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SAG
Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return

Sonora Investment Management's CKPT Position: Q3 2021 in Review

Sonora Investment Management held its Checkpoint Therapeutics (CKPT) position steady in Q3 2021 at 12 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1076.

Sonora Investment Management first reported a position in CKPT in Q2 2021 and has held it in 2 quarters since. 67 funds tracked by Wall St. Rank hold CKPT as of Q3 2021.

  • Sonora Investment Management held 12 shares of Checkpoint Therapeutics worth $0 as of Q3 2021.
  • Sonora Investment Management left its Checkpoint Therapeutics share count unchanged in Q3 2021.
  • Checkpoint Therapeutics made up ﹤0.01% of Sonora Investment Management's portfolio in Q3 2021, its #1076 holding.
  • Sonora Investment Management first reported a position in Checkpoint Therapeutics in Q2 2021 and has held it in 2 quarters since.
  • 67 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q3 2021.

Based on Sonora Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.